Breast Implant Safety
The short answer
Breast Implant Safety summarizes FDA age rules, device limitations, silicone rupture imaging, warnings, and reported systemic symptoms. It may suit patients considering implants or reviewing long-term follow-up after augmentation. In Northglenn, Dr. John Samas reviews your anatomy, your health history and your goals before recommending a plan.
What the FDA actually says about implants, stated plainly and without the numbers nobody can substantiate.
In short
What else should you know?
Breast implants are regulated medical devices with a well documented safety profile, a mandatory FDA boxed warning, and known risks that every patient should understand before surgery.
They are not lifetime devices, silicone gel rupture is often silent so periodic imaging is recommended, and there are two specific conditions, BIA-ALCL and reported systemic symptoms, that belong in the conversation.
Age and device type
Who the FDA permits implants for
For breast augmentation, the FDA sets a minimum age of 18 for saline implants and 22 for silicone gel implants. Reconstruction after mastectomy is handled under different rules.
The two device types behave differently after placement and that difference drives the whole follow-up conversation. Saline deflation is visible, because the shape of the breast changes as the saline is absorbed. Silicone gel rupture is frequently silent, so it is detected by imaging rather than by looking.
If you are still deciding between an implant and using your own fat, the implants versus fat transfer comparison sets the two options against each other, and breast augmentation describes the operation itself.
Follow-up
What the FDA recommends after placement
Follow your device labeling and Dr. Samas's advice, since the schedule can vary by implant.
- Silicone gel implants: periodic imaging for silent rupture, ultrasound or MRI, first at 5 to 6 years after placement.
- Silicone gel implants after that: repeat imaging every 2 to 3 years.
- Saline implants: no routine rupture imaging, because deflation is apparent.
- Keep the device card you are given after surgery. It identifies exactly what was placed.
- Report new breast changes, swelling, pain, or a change in shape rather than waiting for a scheduled visit.
- Continue routine breast screening appropriate to your age and history, and tell the imaging facility that you have implants.
Before surgery
The paperwork exists for a reason
These requirements are federal, they apply to every compliant practice, and they are worth reading rather than signing.
- Every breast implant sold in the United States carries an FDA boxed warning.
- The FDA requires a patient decision checklist to be reviewed and signed before implant surgery.
- The manufacturer's labeling for your specific implant sets out its own follow-up guidance.
- You receive a device card after surgery identifying the implants placed. Keep it with your medical records.
- Augmentation adds volume and does not lift the breast. If the nipple sits low relative to the crease, a lift is the operation being discussed.
BIA-ALCL
What it is, accurately
Breast implant associated anaplastic large cell lymphoma is a lymphoma. It is not breast cancer, and it arises in the scar capsule that forms around an implant rather than in breast tissue.
Risk is higher with textured implants than with smooth implants. The FDA describes the individual risk as low while treating the condition itself as serious, and importantly it does not recommend removing implants in patients who have no symptoms.
The symptoms that matter are persistent swelling, a fluid collection around the implant, a mass, or pain, generally appearing years after placement rather than in the early recovery period. Any of those should be assessed. We do not publish an incidence figure for BIA-ALCL, because the FDA states that incidence cannot be calculated from its data, and a number invented for reassurance is worth nothing. If you are considering having implants taken out, see breast implant removal.
Reported systemic symptoms
Breast implant illness, without overreaching in either direction
Some patients with breast implants report systemic symptoms including fatigue, joint and muscle pain, and difficulty concentrating. These reports are taken seriously enough that they appear in the FDA mandated boxed warning carried by every implant sold in the United States.
The FDA states that the cause is poorly understood. That is the accurate position, and it sits between two claims you will see online that both go too far: that the symptoms are not real, and that implants cause autoimmune disease. Neither is supported.
What that means practically is that if you have implants and you are experiencing these symptoms, it is a conversation to have rather than a question to research alone. Bring it to a consultation.
FAQ
Implant safety questions
This page is general information. Candidacy, recovery and what to expect are discussed at your consultation.
Next
Keep reading
